Opus Point Partners Management, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
Opus Point Partners Management, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$489,000
+14.3%
11,2500.0%0.72%
+24.8%
Q1 2019$428,000
-11.6%
11,2500.0%0.58%
-45.5%
Q4 2018$484,000
-12.5%
11,2500.0%1.06%
-19.3%
Q3 2018$553,000
+37.9%
11,250
-10.0%
1.32%
+51.7%
Q2 2018$401,000
+3.1%
12,5000.0%0.87%
+14.0%
Q1 2018$389,000
-65.9%
12,500
-50.0%
0.76%
-22.7%
Q4 2017$1,141,000
+21.5%
25,0000.0%0.99%
+17.2%
Q3 2017$939,000
-21.3%
25,0000.0%0.84%
-23.0%
Q2 2017$1,193,000
-47.7%
25,000
-50.0%
1.09%
-35.4%
Q1 2017$2,280,000
+41.2%
50,0000.0%1.69%
+31.5%
Q4 2016$1,615,000
-5.6%
50,0000.0%1.29%
+34.2%
Q3 2016$1,711,000
-8.0%
50,000
+42.4%
0.96%
-33.3%
Q1 2016$1,860,000
+26.8%
35,110
+83.7%
1.44%
+48.4%
Q4 2015$1,467,000
+70.0%
19,110
-9.0%
0.97%
+103.1%
Q3 2015$863,000
-74.0%
21,000
-55.3%
0.48%
-81.9%
Q2 2015$3,324,000
+7.1%
47,000
+34.5%
2.63%
+1.2%
Q1 2015$3,105,00034,9492.60%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tamarack Advisers, LP 360,000$21,845,0006.19%
Gagnon Advisors, LLC 213,217$12,938,0004.92%
GAGNON SECURITIES LLC 499,333$30,300,0004.30%
Spyglass Capital Management LLC 2,117,673$128,500,0002.86%
NEUMEIER POMA INVESTMENT COUNSEL LLC 646,530$39,231,0002.30%
Paulson & Co. 1,273,161$77,255,0001.85%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 212,112$12,871,0001.44%
Tygh Capital Management, Inc. 152,332$9,244,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,147,000$69,600,0001.24%
Rock Springs Capital Management LP 1,025,000$62,197,0001.23%
View complete list of PACIRA PHARMACEUTICALS INC shareholders